1 - 25 of 34 results for author:"Matesanz F." in Literature citations
Results Customize
› Repeat search in UniProtKB (16)
| Replication study of 10 genes showing evidence for association with multiple sclerosis: validation of TMEM39A, IL12B and CBLB genes. Varade J., Comabella M., Ortiz M.A., Arroyo R., Fernandez O., Pinto-Medel M.J., Fedetz M., Izquierdo G., Lucas M., Gomez C.L. et al. Mult. Scler. 18:959-965(2012) · Mapped (13) |
| Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosis. Canto E., Reverter F., Morcillo-Suarez C., Matesanz F., Fernandez O., Izquierdo G., Vandenbroeck K., Rodriguez-Antiguedad A., Urcelay E., Arroyo R. et al. Mult. Scler. 18:983-990(2012) · Mapped (4) |
| High ACSL5 transcript levels associate with systemic lupus erythematosus and apoptosis in Jurkat T lymphocytes and peripheral blood cells. Catala-Rabasa A., Ndagire D., Sabio J.M., Fedetz M., Matesanz F., Alcina A. PLoS ONE 6:e28591-e28591(2011) · Mapped (3) |
| ANKRD55 and DHCR7 are novel multiple sclerosis risk loci. Alloza I., Otaegui D., de Lapuente A.L., Antiguedad A., Varade J., Nunez C., Arroyo R., Urcelay E., Fernandez O., Leyva L. et al. Genes Immun. 13:253-257(2012) · Mapped (4) |
| A cytokine gene screen uncovers SOCS1 as genetic risk factor for multiple sclerosis. Vandenbroeck K., Alvarez J., Swaminathan B., Alloza I., Matesanz F., Urcelay E., Comabella M., Alcina A., Fedetz M., Ortiz M.A. et al. Genes Immun. 13:21-28(2012) · Mapped (2) |
| Interaction of PLP with GFP-MAL2 in the human oligodendroglial cell line HOG. Bello-Morales R., Perez-Hernandez M., Rejas M.T., Matesanz F., Alcina A., Lopez-Guerrero J.A. PLoS ONE 6:e19388-e19388(2011) · Mapped (14) |
| Members 6B and 14 of the TNF receptor superfamily in multiple sclerosis predisposition. Blanco-Kelly F., Alvarez-Lafuente R., Alcina A., Abad-Grau M.M., de Las Heras V., Lucas M., de la Concha E.G., Fernandez O., Arroyo R., Matesanz F. et al. Genes Immun. 12:145-148(2011) · Mapped (6) |
| Replication of top markers of a genome-wide association study in multiple sclerosis in Spain. Cavanillas M.L., Fernandez O., Comabella M., Alcina A., Fedetz M., Izquierdo G., Lucas M., Cenit M.C., Arroyo R., Vandenbroeck K. et al. Genes Immun. 12:110-115(2011) · Mapped (29) |
| CD40: novel association with Crohn's disease and replication in multiple sclerosis susceptibility. Blanco-Kelly F., Matesanz F., Alcina A., Teruel M., Diaz-Gallo L.M., Gomez-Garcia M., Lopez-Nevot M.A., Rodrigo L., Nieto A., Cardena C. et al. PLoS ONE 5:e11520-e11520(2010) · Mapped (5) |
| The autoimmune disease-associated KIF5A, CD226 and SH2B3 gene variants confer susceptibility for multiple sclerosis. Alcina A., Vandenbroeck K., Otaegui D., Saiz A., Gonzalez J.R., Fernandez O., Cavanillas M.L., Cenit M.C., Arroyo R., Alloza I. et al. Genes Immun. 11:439-445(2010) · Mapped (11) |
| Validation of the CD6 and TNFRSF1A loci as risk factors for multiple sclerosis in Spain. Swaminathan B., Matesanz F., Cavanillas M.L., Alloza I., Otaegui D., Olascoaga J., Cenit M.C., de las Heras V., Barcina M.G., Arroyo R. et al. J. Neuroimmunol. 223:100-103(2010) · Mapped (18) |
| STAT3 locus in inflammatory bowel disease and multiple sclerosis susceptibility. Cenit M.C., Alcina A., Marquez A., Mendoza J.L., Diaz-Rubio M., de las Heras V., Izquierdo G., Arroyo R., Fernandez O., de la Concha E.G. et al. Genes Immun. 11:264-268(2010) · Mapped (7) |
| Polymorphisms in the IL2, IL2RA and IL2RB genes in multiple sclerosis risk. Cavanillas M.L., Alcina A., Nunez C., de las Heras V., Fernandez-Arquero M., Bartolome M., de la Concha E.G., Fernandez O., Arroyo R., Matesanz F. et al. Eur. J. Hum. Genet. 18:794-799(2010) · Mapped (23) |
| Tag-SNP analysis of the GFI1-EVI5-RPL5-FAM69 risk locus for multiple sclerosis. Alcina A., Fernandez O., Gonzalez J.R., Catala-Rabasa A., Fedetz M., Ndagire D., Leyva L., Guerrero M., Arnal C., Delgado C. et al. Eur. J. Hum. Genet. 18:827-831(2010) · Mapped (16) |
| Hexose-6-phosphate dehydrogenase: a new risk gene for multiple sclerosis. Alcina A., Ramagopalan S.V., Fernandez O., Catala-Rabasa A., Fedetz M., Ndagire D., Leyva L., Arnal C., Delgado C., Lucas M. et al. Eur. J. Hum. Genet. 18:618-620(2010) · Mapped (2) |
| Characterization of the MAL2-positive compartment in oligodendrocytes. Bello-Morales R., de Marco M.C., Aranda J.F., Matesanz F., Alcina A., Lopez-Guerrero J.A. Exp. Cell Res. 315:3453-3465(2009) · Mapped (3) |
| Multiple sclerosis association study with the TENR-IL2-IL21 region in a Spanish population. Fedetz M., Ndagire D., Fernandez O., Leyva L., Guerrero M., Arnal C., Lucas M., Izquierdo G., Delgado C., Alcina A. et al. Tissue Antigens 74:244-247(2009) · Mapped (14) |
| IL2RA/CD25 gene polymorphisms: uneven association with multiple sclerosis (MS) and type 1 diabetes (T1D). Alcina A., Fedetz M., Ndagire D., Fernandez O., Leyva L., Guerrero M., Abad-Grau M.M., Arnal C., Delgado C., Lucas M. et al. PLoS ONE 4:e4137-e4137(2009) · Mapped (8) |
| The T244I variant of the interleukin-7 receptor-alpha gene and multiple sclerosis. Alcina A., Fedetz M., Ndagire D., Fernandez O., Leyva L., Guerrero M., Arnal C., Delgado C., Matesanz F. Tissue Antigens 72:158-161(2008) · Mapped (2) |
| Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations. Kristjansdottir G., Sandling J.K., Bonetti A., Roos I.M., Milani L., Wang C., Gustafsdottir S.M., Sigurdsson S., Lundmark A., Tienari P.J. et al. J. Med. Genet. 45:362-369(2008) · Mapped (12) |
| IL2RA/CD25 polymorphisms contribute to multiple sclerosis susceptibility. Matesanz F., Caro-Maldonado A., Fedetz M., Fernandez O., Milne R.L., Guerrero M., Delgado C., Alcina A. J. Neurol. 254:682-684(2007) · Mapped (6) |
| OAS1 gene haplotype confers susceptibility to multiple sclerosis. Fedetz M., Matesanz F., Caro-Maldonado A., Fernandez O., Tamayo J.A., Guerrero M., Delgado C., Lopez-Guerrero J.A., Alcina A. Tissue Antigens 68:446-449(2006) · Mapped (5) |
| The 1858T PTPN22 gene variant contributes to a genetic risk of type 1 diabetes in a Ukrainian population. Fedetz M., Matesanz F., Caro-Maldonado A., Smirnov I.I., Chvorostinka V.N., Moiseenko T.A., Alcina A. Tissue Antigens 67:430-433(2006) · Mapped (6) |
| IFNAR1 and IFNAR2 polymorphisms confer susceptibility to multiple sclerosis but not to interferon-beta treatment response. Leyva L., Fernandez O., Fedetz M., Blanco E., Fernandez V.E., Oliver B., Leon A., Pinto-Medel M.J., Mayorga C., Guerrero M. et al. J. Neuroimmunol. 163:165-171(2005) · Mapped (4) |
| Effects of the multiple sclerosis associated -330 promoter polymorphism in IL2 allelic expression. Matesanz F., Fedetz M., Leyva L., Delgado C., Fernandez O., Alcina A. J. Neuroimmunol. 148:212-217(2004) · Mapped (12) |